Our Services
The Irish Medicines in Pregnancy Service (IMPS), is a multidisciplinary service involving collaboration between specialist healthcare professionals in obstetrics, maternal-fetal medicine, midwifery and pharmacy. IMPS aims to support safe and effective use of medicines before, during and after pregnancy through information, advocacy, education and research. Below you will find some archived resources which we have produced or contributed to. Please note, the information contained in these documents was accurate at the time of publication.
IMPS Insights
- Summer Insights 2026 – Click here for video recording. Click here for Supplementary materials
- Spring Insights 2026 – Click here to view the video recording. Click here to access Supplementary materials
Articles and Publications
- Infliximab use in pregnancy or breastfeeding – Implications for infant vaccination. Rotunda GP Connect. Issue V1 (May 2022)
- Ondansetron should remain a potential treatment option for women with hyperemesis gravidarum. Rotunda GP Connect. Issue 008 (Feb 2020)
- The Maternity-Pharmacy Axis- Caring for women before, during and after pregnancy. Dr Claire McCarthy. Irish Pharmacy News (November 2022)
- Caring for Women with Epilepsy in your Pharmacy. Dr Nicola Maher. Irish Pharmacy News (April 2022)
- Safety first is urged with modafinil use. Forum. Journal of the Irish College of General Practitioners (ICGP) (June 2022)
- The use of newer anti-seizure medicines in women with epilepsy in pregnancy: A case series’ https://pubmed.ncbi.nlm.nih.gov/39927179/
- Exploring health information and resource needs of women with epilepsy in Ireland from preconception to postpartum: A qualitative study https://pubmed.ncbi.nlm.nih.gov/41579789/
- Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women https://pubmed.ncbi.nlm.nih.gov/41532034/
- Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries https://pubmed.ncbi.nlm.nih.gov/35162405/
- Vaccine Willingness and Impact of the COVID-19 Pandemic on Women’s Perinatal Experiences and Practices-A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic’ https://pubmed.ncbi.nlm.nih.gov/33805097/
- Medication use in pregnancy and lactation: A gap to be filled in postgraduate medical education https://pubmed.ncbi.nlm.nih.gov/33725505/
- The importance of collaboration in maternal medicine: A retrospective descriptive study of a maternal multidisciplinary team meeting https://pubmed.ncbi.nlm.nih.gov/38726545/
Information resources and shared decision making tools
Shared decision making tools for COVID-19 and RSV immunizations
Educational events
- Programme for RCPI/IMPS study day: 2021, 2022, 2023, 2024
- Programme for the ENTIS Conference. Dublin 2023
IMPS/ENTIS Position Statements
- Paracetamol and Pregnancy
- Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated
- Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder
- Position Statement on Ondansetron Use in Pregnancy.
- Modafinil and the risk of congenital malformations: Implications for practice. Irish Medicines in Pregnancy Service (IMPS). (Oct 2021)
Other media/Social media
- Immunisation Week – Rotunda Instagram (April 2021)
- Real talk with real mums – Episode 9 Mental Health. Brian Cleary (Nov 2019)
Sign Up to IMPS Insights to receive updates, articles and news from the Irish Medicines In Pregnancy Service